source
- Biogen validated the Alzheimer’s tau theory. CEO Viehbacher still isn’t betting the storeWith so many unknowns, Biogen is carefully eyeing its next-gen Alzheimer’s treatment diranersen as a high-risk, high-reward project with the potential for a major payout around 2030.BioSpace · 10m ago↗ source
- Is it safe to drink Red Bull and vodka? Questionable research tied to energy drink giant has shaped policyStudies tied to Red Bull helped block warning labels about drinking alcohol along with energy drinks. Independent studies report risks in mixing the two.STAT · 22m ago↗ source
- FDA advisory panel votes 9-3 against Capricor's Duchenne therapy deramiocelDuring an FDA Cellular, Tissue, and Gene Therapies Advisory Committee meeting, reviewers focused on the Phase 3 HOPE-3 trial's secondary cardiac endpoint and described the data as very fragile. The…